
Sign up to save your podcasts
Or


Hans Keirstead, PhD, is the Chairman of the Board at Immunis, a biotechnology company researching and developing immune secretome products to address age-driven immune deficits. In this episode, Chris and Hans discuss Immunis' approach to targeting the aging immune system as a key driver of age-related disease. They explore the potential of immune secretome factors to restore youthful immune function, the promising results from Immunis' preclinical and early clinical studies, and the future of immune-modulating therapeutics to extend healthspan.
THE FINER DETAILS
QUOTES
LINK TO PAPER
Stem cell secretome treatment improves whole-body metabolism, reduces adiposity, and promotes skeletal muscle function in aged mice
By BioAge Labs5
1111 ratings
Hans Keirstead, PhD, is the Chairman of the Board at Immunis, a biotechnology company researching and developing immune secretome products to address age-driven immune deficits. In this episode, Chris and Hans discuss Immunis' approach to targeting the aging immune system as a key driver of age-related disease. They explore the potential of immune secretome factors to restore youthful immune function, the promising results from Immunis' preclinical and early clinical studies, and the future of immune-modulating therapeutics to extend healthspan.
THE FINER DETAILS
QUOTES
LINK TO PAPER
Stem cell secretome treatment improves whole-body metabolism, reduces adiposity, and promotes skeletal muscle function in aged mice

2,680 Listeners

26,351 Listeners

2,447 Listeners

1,093 Listeners

394 Listeners

9,198 Listeners

1,603 Listeners

9,956 Listeners

499 Listeners

5,488 Listeners

29,264 Listeners

16,096 Listeners

184 Listeners

542 Listeners

594 Listeners